Dr. Juan Alderuccio is a clinical investigator specializing in lymphoma drug development at the University of Miami Sylvester Comprehensive Cancer Center, where he serves as Clinical Research Site Disease Group Leader of the Lymphoma Section and principal investigator on multiple clinical trials.
His research centers on designing innovative clinical trials and integrating circulating tumor DNA (ctDNA) into treatment decision-making for patients with indolent and aggressive B-cell lymphomas. He has been involved in the development of multiple investigator-initiated, NCI, and industry-supported clinical trials. Dr. Alderuccio's work has been supported by the Lymphoma Research Foundation, the US Department of Defense, and the American Society of Hematology Scholar Award.